| 000 | 01227 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250514040030.0 | ||
| 264 | 0 | _c20020813 | |
| 008 | 200208s 0 0 eng d | ||
| 022 | _a1473-7140 | ||
| 024 | 7 |
_a10.1586/14737140.1.2.222 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFelip, E | |
| 245 | 0 | 0 |
_aNew strategies in the treatment of resectable non-small cell lung cancer. _h[electronic resource] |
| 260 |
_bExpert review of anticancer therapy _cAug 2001 |
||
| 300 |
_a224-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xclassification |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xclassification |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aRosell, R | |
| 773 | 0 |
_tExpert review of anticancer therapy _gvol. 1 _gno. 2 _gp. 224-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/14737140.1.2.222 _zAvailable from publisher's website |
| 999 |
_c12004273 _d12004273 |
||